Tilray Inc. ($TLRY) Stock Forecast: Down 6.4% Today

What is Tilray Inc.?

Tilray Brands Inc. (NASDAQ: TLRY) is a cannabis company that also owns the craft beer brand 10 Barrel Brewing. Today, TLRY experienced a significant bearish movement in the stock market.

Why is Tilray Inc. going down?

TLRY stock is down 6.4% on May 5, 2026 14:21

• Tilray's stock price dropped by 4.2% to $5.90, trading below key moving averages, following a wider-than-expected EPS loss of -$0.24 despite beating revenue estimates.
• The broader market also experienced losses, with the NASDAQ Composite Index dropping 0.19% and the Dow Jones Industrial Average falling 1.13%, contributing to Tilray's decline.
• The launch of two new ready-to-drink cocktails by 10 Barrel Brewing, a brand under Tilray, did not seem to positively impact the stock price, as investors may be more focused on the company's financial performance and profitability.
• Analysts' consensus "Hold" rating and lowered price targets suggest caution among investors, reflecting concerns about Tilray's current financial outlook and market conditions.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands (NASDAQ:TLRY) Stock Price Down 4.2% - Should You Sell?

Tilray Brands (NASDAQ:TLRY) saw its stock price drop by 4.2% to $5.90, trading below its 50- and 200-day moving averages with increased volume. The company reported a wider-than-expected EPS loss of -$0.24, despite revenue beating estimates, and remains unprofitable. Analysts currently have a consensus "Hold" rating with an average price target of $11.50, though some have recently lowered their targets.

https://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-stock-price-down-42-should-you-sell-2026-05-04/

Tilray Brands Inc. stock falls Monday, underperforms market

Tilray Brands Inc. (TLRY) shares fell 4.22% on Monday, closing at $5.90, as the broader stock market also experienced losses. This marks the second consecutive day of declines for Tilray's stock. The NASDAQ Composite Index dropped 0.19%, and the Dow Jones Industrial Average fell 1.13% during the trading session.

https://www.marketwatch.com/data-news/tilray-brands-inc-stock-falls-monday-underperforms-market-e6d49e9f-b260fbb27089

10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails

10 Barrel Brewing has expanded its ready-to-drink (RTD) cocktail line with two new products: Clean Slate and Salty Sips. Clean Slate is a functional non-alcoholic beverage with a Vitamin B blend, Lion’s Mane, Guarana & Ginseng, and caffeine, designed for focus and energy. Salty Sips is a low-sugar vodka refresher made with real watermelon juice and sea salt, featuring 5% ABV and only two grams of sugar.

https://www.globenewswire.com/news-release/2026/05/04/3286553/0/en/10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-line-with-functional-n-a-and-low-sugar-cocktails.html

One has 113 mg caffeine, the other 2 g sugar: 10 Barrel expands RTDs

10 Barrel Brewing, a brand under Tilray Brands, has launched two new ready-to-drink (RTD) cocktails: Clean Slate and Salty Sips. Clean Slate is a non-alcoholic functional beverage containing 113 mg of caffeine and beneficial ingredients, while Salty Sips is a 5% ABV vodka refresher with only 2 grams of sugar. Both new products, made with real fruit juices and sea salt, are initially available in the Pacific Northwest with plans for West Coast expansion.

https://www.stocktitan.net/news/TLRY/10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-csofp0gtdnrp.html

Tilray Brands Inc.

Tilray Brands Inc. announced the release of two new ready-to-drink cocktails, Clean Slate and Salty Sips, from its 10 Barrel Brewing craft beer brand. Following this announcement, Tilray's shares (T.TLRY) were trading down $0.04 at $8.34. The news highlights Tilray's expansion in the beverage market.

http://www.baystreet.ca/stocksinplayarticles/47084/Tilray-Brands-Inc47084

Trending Today

IDEXX Laboratories Inc. ($IDXX) Stock Forecast: Up 3.0% Today

Nasdaq Inc. ($NDAQ) Stock Forecast: Down 3.4% Today

MPLX LP Representing Limited Partner Interests ($MPLX) Stock Forecast: Down 2.6% Today

ServiceNow Inc. ($NOW) Stock Forecast: Down 5.3% Today

Vertex Pharmaceuticals Incorporated ($VRTX) Stock Forecast: Down 1.5% Today

BioMarin Pharmaceutical Inc. ($BMRN) Stock Forecast: Up 0.8% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Up 1.7% Today

Amphenol Corporation ($APH) Stock Forecast: Down 2.2% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Down 6.5% Today

Micron Technology Inc. ($MU) Stock Forecast: Up 9.7% Today

Tilray Inc. Price History

27.03.2026 - TLRY Stock was down 5.3%

• Investors opted to take profits today amidst Tilray's stock decline, following a period of volatility and speculation.
• Concerns arose among investors due to a director's sale of over 33,000 company shares, potentially impacting outlook and causing fears of dilution.
• Although positive developments such as U.S. cannabis rescheduling and the company's expansion plans emerged, the stock's decline suggests some skepticism among investors regarding the recent surge.
• Tilray's larger-than-expected quarterly loss and negative net margins may have also influenced the stock's downturn, prompting an evaluation of the company's financial standing in light of sector trends.

29.03.2026 - TLRY Stock was down 6.3%

• The stock price of Tilray dropped by 4.8% to $6.56, nearing its 52-week low and trading below its 200-day moving average, signaling bearish sentiment among investors.
• Despite the launch of new products by its subsidiary Manitoba Harvest, Tilray's stock faced continued selling pressure and technical indicators suggest a downside risk, potentially due to the company missing EPS estimates in the last quarter and reporting negative net margins.
• The underperformance of Tilray's stock compared to the broader market indices like the NASDAQ Composite and Dow Jones Industrial Average indicates specific challenges faced by the company, potentially related to its financial performance and market positioning.
• The overall US cannabis market is projected to grow significantly in the coming years, providing a positive industry outlook, but Tilray's specific stock movement today may be influenced by internal factors such as financial results and market sentiment rather than broader industry trends.

22.03.2026 - TLRY Stock was up 14.6%

• The surge in Tilray Brands Inc. (TLRY) can be linked to the filing of additional legal exhibits related to a registration statement. This move likely boosted investor confidence in the company's adherence to regulations and transparency.
• Despite the notification of an insider selling 232,872 shares, the market appeared more interested in the registration of 398,666 resalable common shares, issued for acquiring the Lyphe Group. This development hinted at potential growth avenues for the company.
• The stock's positive trajectory might also reflect a recovery from the previous day's downturn, where it performed below the market average. Investors seem to perceive this as a favorable moment to purchase following the recent price dip.
• In summary, the optimistic market sentiment surrounding Tilray Brands Inc. could stem from its regulatory compliance, growth potential from acquisitions, and a rebound from the previous day's underperformance.

28.03.2026 - TLRY Stock was down 5.3%

• The exclusive launch of Manitoba Harvest's Superfood Smoothie Boosters at Sprouts Farmers Market suggests potential competition in the health and wellness sector, impacting investor sentiment towards Tilray.
• Concerns about growing competition and market saturation in the US cannabis market may have prompted a sell-off of TLRY shares.
• Anticipation surrounding Tilray's upcoming Q3 earnings report, which showed a wider loss than expected but beat revenue estimates, created uncertainty among investors despite the company's market outperformance.
• The market's mixed reactions to Tilray's Q3 earnings, with the stock price dropping despite surpassing revenue expectations, may have led investors to reassess the company's financial standing and future outlook.

23.03.2026 - TLRY Stock was up 8.6%

• Tilray's stock price rose by more than 30% due to discussions about the possible reclassification of cannabis, which could support the company's plans for growth in the US market.
• There is excitement among investors regarding the potential regulatory changes that could lead to tax benefits and smoother operations for cannabis firms.
• Tilray's preparedness to tap into the US medical cannabis sector after a potential reclassification showcases strategic opportunities for growth and market expansion.
• By collaborating with BrewDog USA, Tilray is demonstrating a diverse approach to innovation and product offerings, which is contributing to its optimistic market sentiment and upward trajectory.

24.03.2026 - TLRY Stock was down 12.9%

• The stock price of Tilray Brands plummeted by 11.8% following insider selling of over 33,000 shares by a director, leading to increased trading volume and negative investor sentiment.
• Despite optimism in the cannabis sector due to potential reclassification of cannabis to Schedule III, concerns about potential dilution, wider-than-expected quarterly losses, and negative net margins contributed to the bearish movement.
• While there was speculation and anticipation surrounding the Trump administration's possible rescheduling of cannabis, the lack of official confirmation led to uncertainty and a sell-off in Tilray's stock.
• Tilray's readiness to expand into the U.S. medical cannabis market post-rescheduling highlights the company's strategic positioning, but until concrete regulatory changes are announced, the stock may continue to face volatility and downward pressure.

21.03.2026 - TLRY Stock was down 5.2%

• TLRY experienced a strong bearish movement today despite recent positive news and stock price gains in the past few days.
• The stock's poor performance could be attributed to the challenges faced in the legal marijuana market, including restrictive regulations on branding and advertising, intense competition, and uncertainty surrounding potential U.S. legalization.
• Despite reaffirming its leadership in medical cannabis and positive company news, the stock's reaction indicates a stock-specific response rather than a broader sector trend.
• The bearish movement today may be a result of profit-taking by investors following the recent price increases, as well as concerns about the company's ability to overcome regulatory hurdles and achieve sustained profitability in a competitive market.

14.03.2026 - TLRY Stock was up 8.5%

• The stock had a strong bullish movement today, closing 4.5% higher at $6.75.
• This positive momentum could be attributed to the recent launch of PORTAL™, a new high-intensity cannabis brand targeting experienced consumers in Canada, filling a market gap and potentially driving investor optimism.
• Despite facing legal challenges, such as the $11.3 million lawsuit from the Bob Marley estate over licensing royalties, Tilray's strategic product offerings and market expansion efforts seem to have resonated positively with investors, leading to today's bullish market movement.

13.03.2026 - TLRY Stock was up 5.2%

• Despite recent declines in the stock price and mixed trading sessions, today's bullish movement suggests a potential shift in investor sentiment.
• The launch of PORTAL™, a new high-intensity cannabis brand targeting experienced consumers, could have positively impacted the stock price as it signals the company's efforts to expand its product offerings and cater to specific market segments.
• The ongoing legal battle with the Bob Marley estate over licensing royalties might have initially caused uncertainty among investors, leading to the recent declines. However, the bullish movement today could indicate that investors are optimistic about a potential resolution or are focusing more on the company's product innovations.
• It's essential for investors to closely monitor any updates regarding the legal dispute and the company's financial performance to make informed decisions about their investments in Tilray Brands Inc.

04.04.2026 - TLRY Stock was down 5.0%

• The stock's downward trend today could be linked to Tilray's larger-than-expected EPS loss, causing investor concerns over its financial standing.
• Despite positive remarks from the CEO regarding potential benefits from US cannabis reclassification, the market reaction may stem from Tilray's current lack of cannabis sales in the US, focusing on other product lines instead.
• Analyst sentiment on Tilray remains mixed, with an average "Hold" rating and insider share selling, possibly contributing to the stock's bearish sentiment.
• Market dynamics, including the NASDAQ Composite Index uptrend and the Dow Jones Industrial Average decline, may have further driven the negative pressure on Tilray's stock.

04.04.2026 - TLRY Stock was down 5.1%

• The company faced potential investor concerns with the launch of two new ready-to-drink cocktails by brand 10 Barrel Brewing, a Tilray subsidiary, raising worries about moving away from their core cannabis business.
• Despite surpassing revenue expectations, the stock's decline might be linked to Tilray's larger-than-expected EPS loss, creating uncertainties around the company's profitability and future growth.
• CEO Irwin Simon's positive remarks on the potential reclassification of US cannabis were overshadowed by negative factors like insider selling, stock trading below key moving averages, and overall market sentiment towards the stock.

05.04.2026 - TLRY Stock was down 6.4%

• Tilray's stock price dropped by 4.2% to $5.90, trading below key moving averages, following a wider-than-expected EPS loss of -$0.24 despite beating revenue estimates.
• The broader market also experienced losses, with the NASDAQ Composite Index dropping 0.19% and the Dow Jones Industrial Average falling 1.13%, contributing to Tilray's decline.
• The launch of two new ready-to-drink cocktails by 10 Barrel Brewing, a brand under Tilray, did not seem to positively impact the stock price, as investors may be more focused on the company's financial performance and profitability.
• Analysts' consensus "Hold" rating and lowered price targets suggest caution among investors, reflecting concerns about Tilray's current financial outlook and market conditions.